Review

Accepted on 31 Oct 2024

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line -An Expert Opinion

in Gastrointestinal Cancers: Colorectal Cancer

Carmine Pinto
Sara Lonardi
Evaristo Maiello
Erika Martinelli
Michele Prisciandaro
Lisa Salvatore
Andrea Sartore-Bianchi
Mario Scartozzi
Giuseppe Aprile
Chiara Cremolini

Frontiers in Oncology

doi 10.3389/fonc.2024.1502185

Clinical Trial

Accepted on 31 Oct 2024

A Randomized Phase 3 Trial of Total Neoadjuvant Therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy and surgery) vs Standard Long-term Chemoradiation Therapy (neoadjuvant chemoradiation, surgery and adjuvant chemotherapy) in Locally Advanced Rectal Cancer

in Gastrointestinal Cancers: Colorectal Cancer

Freshte Foroughi
Seyed Alireza Javadinia
Roham Salek

Frontiers in Oncology

doi 10.3389/fonc.2024.1468279

Original Research

Published on 31 Oct 2024

Comparative prediction of lymph node metastasis in pT1 colorectal cancer among Western and Japanese guidelines

in Gastrointestinal Cancers: Colorectal Cancer

Fumiaki Tanino
Ken Yamashita
Shin Morimoto
Yudai Takehara
Noriko Yamamoto
Yuki Kamigaichi
Tomoyuki Nishimura
Hidenori Tanaka
Hidehiko Takigawa
Yuji Urabe

Frontiers in Oncology

doi 10.3389/fonc.2024.1475270

392 views

Original Research

Published on 31 Oct 2024

Performance of DNA methylation and blood-borne tumor indicators in detecting colorectal neoplasia and adenomas: a comparative study with the fecal occult blood test

in Gastrointestinal Cancers: Colorectal Cancer

Ming Chen
Ji Zhang
Bin Xu
Bilian Yao
Zhenzhen Wang
Ying Chen
Kaiyu Cai
Chenli Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1373088

314 views

Systematic Review

Published on 30 Oct 2024

Radiomics in precision medicine for colorectal cancer: a bibliometric analysis (2013–2023)

in Gastrointestinal Cancers: Colorectal Cancer

Hao Li
Yupei Zhuang
Weichen Yuan
Yutian Gu
Xinyan Dai
Muhan Li
Haibin Chen
Hongguang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1464104

673 views

Original Research

Published on 28 Oct 2024

Effectiveness of partial splenic embolization in colorectal cancer patients with chemotherapy-induced thrombocytopenia: results of a single institution retrospective study

in Gastrointestinal Cancers: Colorectal Cancer

Dan Li
Tao Peng
Ke-tong Wu
Yu-ting Huang
Yang Liu
Yuan Wan
Bo Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1468744

289 views

Case Report

Published on 24 Oct 2024

Perirectal angioleiomyoma preoperatively misdiagnosed as rectal cancer: a case report

in Gastrointestinal Cancers: Colorectal Cancer

Wenhan Liu
Xianxiong Wen
Dongping Hu
Hong Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1476084

450 views

Original Research

Published on 17 Oct 2024

Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasms

in Gastrointestinal Cancers: Colorectal Cancer

Na Li
Linguo Wu
Jianduo An

Frontiers in Oncology

doi 10.3389/fonc.2024.1399079

285 views

Original Research

Published on 11 Oct 2024

Development and validation of a clinical prognostic model for BRAF V600E-mutated colorectal cancer patients based on pathological stage, microsatellite status, and primary tumor site

in Gastrointestinal Cancers: Colorectal Cancer

Kai Ou
Xiu Liu
Xiaoting Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1461237

446 views

Systematic Review

Published on 11 Oct 2024

Application of Artificial Intelligence in the diagnosis and treatment of colorectal cancer: a bibliometric analysis, 2004–2023

in Gastrointestinal Cancers: Colorectal Cancer

Lamei Sun
Rong Zhang
Yidan Gu
Lei Huang
Chunhui Jin

Frontiers in Oncology

doi 10.3389/fonc.2024.1424044

787 views

Original Research

Published on 11 Oct 2024

Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resection

in Gastrointestinal Cancers: Colorectal Cancer

Xuan Dai
Yifan Li
Haoran Wang
Zhujiang Dai
Yuanyuan Chen
Yun Liu
Shiyong Huang

Frontiers in Oncology

doi 10.3389/fonc.2024.1402847

406 views

Editorial

Published on 10 Oct 2024

Editorial: Hereditary colorectal cancer syndromes and risk assessment in the era of precision medicine

in Gastrointestinal Cancers: Colorectal Cancer

Kevin McDonnell
Gad Rennert
Gregory E. Idos

Frontiers in Oncology

doi 10.3389/fonc.2024.1474157

393 views

Original Research

Published on 08 Oct 2024

Feasibility of ctDNA in detecting minimal residual disease and predicting recurrence for colorectal cancer liver metastases

in Gastrointestinal Cancers: Colorectal Cancer

Jennifer A. Kalil
Lucyna Krzywon
Stephanie K. Petrillo
Migmar Tsamchoe
Oran Zlotnik
Anthoula Lazaris
Peter Metrakos

Frontiers in Oncology

doi 10.3389/fonc.2024.1418696

598 views

Original Research

Published on 07 Oct 2024

Harnessing the power of AI in precision medicine: NGS-based therapeutic insights for colorectal cancer cohort

in Gastrointestinal Cancers: Colorectal Cancer

Victor Murcia Pienkowski
Piotr Skoczylas
Agata Zaremba
Stanisław Kłęk
Martyna Balawejder
Paweł Biernat
Weronika Czarnocka
Oskar Gniewek
Łukasz Grochowalski
Małgorzata Kamuda

Frontiers in Oncology

doi 10.3389/fonc.2024.1407465

1,060 views

Original Research

Published on 02 Oct 2024

Significance of apparent diffusion coefficient in diagnosis of rectal carcinoma

in Gastrointestinal Cancers: Colorectal Cancer

Milica Šarošković
Miloš Vuković
Stefan Stojanoski
Milica Zorić
Nataša Prvulović Bunović
Milena Spirovski
Igor Nosek

Frontiers in Oncology

doi 10.3389/fonc.2024.1464183

689 views

Original Research

Published on 30 Sep 2024

TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice

in Gastrointestinal Cancers: Colorectal Cancer

Ji Eun Shin
Sung Hee Lim
Jeeyun Lee
Ho Yeong Lim
Young Suk Park
Seung Tae Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1450732

635 views

Navigation group

Articles

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line -An Expert Opinion

A Randomized Phase 3 Trial of Total Neoadjuvant Therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy and surgery) vs Standard Long-term Chemoradiation Therapy (neoadjuvant chemoradiation, surgery and adjuvant chemotherapy) in Locally Advanced Rectal Cancer

Comparative prediction of lymph node metastasis in pT1 colorectal cancer among Western and Japanese guidelines

Performance of DNA methylation and blood-borne tumor indicators in detecting colorectal neoplasia and adenomas: a comparative study with the fecal occult blood test

Radiomics in precision medicine for colorectal cancer: a bibliometric analysis (2013–2023)

Effectiveness of partial splenic embolization in colorectal cancer patients with chemotherapy-induced thrombocytopenia: results of a single institution retrospective study

Perirectal angioleiomyoma preoperatively misdiagnosed as rectal cancer: a case report

Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasms

Development and validation of a clinical prognostic model for BRAF V600E-mutated colorectal cancer patients based on pathological stage, microsatellite status, and primary tumor site

Application of Artificial Intelligence in the diagnosis and treatment of colorectal cancer: a bibliometric analysis, 2004–2023

Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resection

Editorial: Hereditary colorectal cancer syndromes and risk assessment in the era of precision medicine

Feasibility of ctDNA in detecting minimal residual disease and predicting recurrence for colorectal cancer liver metastases

Harnessing the power of AI in precision medicine: NGS-based therapeutic insights for colorectal cancer cohort

Significance of apparent diffusion coefficient in diagnosis of rectal carcinoma

TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice